37818 Federal Register / Vol. 78, No. 121 / Monday, June 24, 2013 / Notices 

Audio participation in this meeting is 

available to the public. The following 

information is provided for individuals 

who wish to participate in this meeting 

by telephone: Toll free number for calls 

originating in the United States: 

1–888–677–1385; Toll free number for 

calls originating outside the United 

States: 1–312–470–7133; the passcode 

for all originating calls is 8094285. 

Please note that this special meeting 

is being held only to provide 

opportunity for the NVAC to provide 

recommendations to the ASH on 

comments to be given to CMS on the 

proposed rule. A decision was made at 

the meeting most recently held by 

NVAC on June 11–12, 2013, that the 

Committee should make 

recommendations to the ASH on the 

proposed rule. Comments on the 

proposed rule are due to be submitted 

to CMS no later than June 25, 2013. The 

number of days between the recent 

NVAC meeting and the due date for the 

comments to CMS is less than 15 days. 

Therefore, notice to the public about the 

NVAC being convened for this specific 

purpose could not be published in the 

Federal Register, as required by the 

Federal Advisory Committee Act, 15 

days prior to the date the special 

meeting is scheduled to be held. 

Dated: June 19, 2013. 

Bruce Gellin, 

Director, National Vaccine Program Office, 

and Executive Secretary, National Vaccine 

Advisory Committee. 

[FR Doc. 2013–14996 Filed 6–21–13; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[CDC–2013–0011; NIOSH–262] 

Request for Information on Toluene 

Diisocyanates 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Request for Information. 

SUMMARY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC) intends to 

evaluate the scientific data on toluene 

diissocyanate (TDI) and other TDI-based 

isocyanate products to develop a 

Criteria Document to establish an 

updated Recommended Exposure Limit 

(REL) for toluene diisocyanate. The 

current NIOSH REL for 2,4–TDI is the 

lowest feasible concentration with no 

ceiling due to the potential 

carcinogenicity of 2,4–TDI. 

NIOSH is requesting information on 

the following: (1) Published and 

unpublished reports and findings from 

in vitro and in vivo toxicity studies with 

toluene diisocyanate; (2) information on 

possible health effects observed in 

workers exposed to toluene 

diisocyanate, including exposure data 

and the method(s) used for sampling 

and analyzing exposures; (3) description 

of work tasks and scenarios with a 

potential for exposure to toluene 

diisocyanate; (4) information on control 

measures (e.g. engineering controls, 

work practices, personal protective 

equipment, exposure data before and 

after implementation of control 

measures) that are being used in 

workplaces with potential exposure to 

toluene diisocyanate; and (5) 

surveillance findings including 

protocol, methods, and results. 

DATES: Public Comment Period: 

Comments must be received August 8, 

2013. 

ADDRESSES: You may submit comments, 

identified by CDC–2013–0011 and 

Docket Number NIOSH–262, by either 

of the two following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: NIOSH Docket Office, Robert 

A. Taft Laboratories, MS–C34, 4676 

Columbia Parkway, Cincinnati, OH 

45226. 

Instructions: All information received 

in response to this notice must include 

the agency name and docket number 

(CDC–2013–0011; NIOSH–262). All 

relevant comments received will be 

posted without change to http:// 

www.regulations.gov, including any 

personal information provided. All 

electronic comments should be 

formatted as Microsoft Word. Please 

make reference to CDC–2013–0011 and 

Docket Number NIOSH–262. 

FOR FURTHER INFORMATION CONTACT: 

Naomi Hudson, Dr.P.H., NIOSH, Robert 

A Taft Laboratories, MS–C32, 4676 

Columbia Parkway, Cincinnati, OH 

45226, telephone (513) 533–8388. 

SUPPLEMENTARY INFORMATION: Toluene 

diisocyanates are colorless to pale 

yellow liquids or solids with a sharp, 

pungent odor. TDI is one of the most 

commonly used diisocyanates. The most 

common formulation of TDI is a mixture 

of two isomers: 80% 2,4–TDI and 20% 

2,6–TDI. Approximately 541 million 

pounds of TDI were used in 2008, and 

527 million pounds of TDI were used in 

2010. 

Occupational exposure occurs during 

production and use of diisocyanates, 

such as the mixing and foaming 

processes in the polyurethane foam 

industry, and during spray adhesive 

application in the automobile and 

furniture industries. TDI is an irritant to 

the eyes, skin, and the gastrointestinal 

and respiratory tracts. Workers exposed 

to TDI may also be sensitized, such that 

they might be subject to asthma attacks. 

In 1996 NIOSH published a NIOSH 

Alert, Preventing Asthma and Death 

from Diisocyanate Exposure [DHHS 

(NIOSH) Publication No. 96–111]. In 

1989, NIOSH published a Current 

Intelligence Bulletin on toluene 

diisocyanate (TDI) and toluenediamine 

(TDA) [DHHS (NIOSH) Publication No. 

90–101] which classified TDI and TDA 

(used in the manufacturing of TDI) as 

potential occupational carcinogens. 

The current NIOSH REL for 2,4–TDI 

is the lowest feasible concentration with 

no ceiling due to the potential 

carcinogenicity of TDI. The OSHA 

permissible exposure limit (PEL) for TDI 

is 0.005 ppm, with a ceiling of 0.02 

ppm. The American Conference of 

Governmental Industrial Hygienists 

(ACGIH) threshold limit value (TLV) for 

TDI is 0.005 ppm with a ceiling of 0.02 

ppm to minimize effects on the 

respiratory tract and to minimize the 

potential for sensitization. 

NIOSH seeks to obtain materials, 

including published and unpublished 

reports and research findings, to 

evaluate the possible health risks of 

occupational exposure to diisocyanates. 

Examples of requested information 

include, but are not limited to, the 

following: 

(1) Identification of industries or 

occupations in which exposures to TDI 

may occur. 

(2) Trends in the production and use 

of TDI. 

(3) Description of work tasks and 

scenarios with a potential for exposure 

to TDI. 

(4) Workplace exposure measurement 

data of TDI in various types of 

industries and jobs. 

(5) Case reports or other health 

information demonstrating potential 

health effects in workers exposed to 

TDI. 

(6) Research findings from in vitro and 

in vivo studies. 

(7) Information on control measures 

(e.g., engineering controls, work 

practices, PPE) being taken to minimize 

worker exposure to TDI. 

(8) Educational materials for worker 

safety and training on the safe handling 

of diisocyanates. 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 78, No. 121 / Monday, June 24, 2013 / Notices 37819 

(9) Data pertaining to the feasibility of 

establishing a more protective REL for 

diisocyanates. 

(10) Names of substitute chemicals or 

processes being used in place of TDI 

and type of work tasks. 

Dated: June 17, 2013. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2013–15040 Filed 6–21–13; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Proposed Projects 

Title: Child Care and Development 

Block Grant Reporting Requirements— 

ACF–700. 

OMB No.: 0970–0430. 

Description: Thee Child Care and 

Development Fund (CCDF) report 

requests annual Tribal aggregate 

information on services provided 

through the CCDF, which is required by 

the CCDF Final Rule (45 FR parts 98 and 

99). Tribal Lead Agencies (TLAs) are 

required to submit annual aggregate data 

appropriate to Tribal programs on 

children and families receiving CCDFfunded child care services. The CCDF 

statute and regulations also require 

TLAs to submit a supplemental 

narrative as part of the ACF–700 report. 

This narrative describes child care 

activities and actions in the TLA’s 

service area. Information from the ACF– 

700 and supplemental narrative report 

will be included in the Secretary’s 

Report to Congress, as appropriate, and 

will be shared with all TLAs to inform 

them of CCDF-funded activities in other 

Tribal programs. 

Respondents: Tribal Governments. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

ACF–700 Report .............................................................................................. 260 1 38 9,880 

Estimated Total Annual Burden 

Hours: 9,880. 

In compliance with the requirements 

of Section 506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Planning, Research 

and Evaluation, 370 L’Enfant 

Promenade SW., Washington, DC 20447, 

Attn: ACF Reports Clearance Officer. 

Email address: 

infocollection@acf.hhs.gov. All requests 

should be identified by the title of the 

information collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2013–14998 Filed 6–21–13; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: ADP & Services Conditions for 

FFP for ACF. 

OMB No.: 0992–0005. 

Description: The Advance Planning 

Document (APD) process, established in 

the rules at 45 CFR Part 95, Subpart F, 

is the procedure by which States request 

and obtain approval for Federal 

financial participation in their cost of 

acquiring Automatic Data Processing 

(ADP) equipment and services. State 

agencies that submit APD requests 

provide the Department of Health and 

Human Services (HHS) with the 

following information necessary to 

determine the States’ needs to acquire 

the requested ADP equipment and/or 

services: 

(1) A statement of need; 

(2) A requirements analysis and 

feasibility study; 

(3) A procurement plan 

(4) A proposed activity schedule; and, 

(5) A proposed budget. 

HHS’ determination of a State 

Agency’s need to acquire requested ADP 

equipment or services is authorized at 

sections 402(a)(5), 452(a)(1), 1902(a)(4) 

and 1102 of the Social Security Act. 

Respondents: States. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

RFP and Contract .......................................................................................... 54 1 .5 4 324 

Emergency Funding Request ........................................................................ 5 .1 2 1 

Biennial Reports ............................................................................................ 26 1 1.50 39 

Advance Planning Document ........................................................................ 34 1 .2 120 4,896 

Operational Advance Planning Document .................................................... 20 1 30 600 

mstockstill on DSK4VPTVN1PROD with NOTICES